Detailed Information

Cited 5 time in webofscience Cited 6 time in scopus
Metadata Downloads

Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy

Full metadata record
DC FieldValueLanguage
dc.contributor.authorSeo, Chung Gyo-
dc.contributor.authorYim, Sun Young-
dc.contributor.authorUm, Soon Ho-
dc.contributor.authorLee, Yoo Ra-
dc.contributor.authorLee, Yoo Jin-
dc.contributor.authorKim, Tae Hyung-
dc.contributor.authorGoh, Hyun Gil-
dc.contributor.authorLee, Young Sun-
dc.contributor.authorSuh, Sang Jun-
dc.contributor.authorHan, Na Yeon-
dc.contributor.authorChoi, Hyuk Soon-
dc.contributor.authorKim, Eun Sun-
dc.contributor.authorKeum, Bora-
dc.contributor.authorSeo, Yeon Seok-
dc.contributor.authorYim, Hyung Joon-
dc.contributor.authorKim, Ji Hoon-
dc.contributor.authorKim, Dong-Sik-
dc.contributor.authorJeen, Yoon Tae-
dc.contributor.authorChun, Hoon Jai-
dc.contributor.authorLee, Hong Sik-
dc.contributor.authorKim, Chang Duck-
dc.description.abstractBackground and aims: Since there is a shortage of liver donors, we investigated recurrence patterns and outcomes after liver resection (LR) to determine the feasibility of salvage liver transplantation (SLT). Methods: We analyzed 468 patients with hepatocellular carcinoma (HCC) within the Milan criteria (MC) who were mainly associated with Hepatitis B virus infection (76.3%) and had undergone curative LR as an initial treatment. Results: The overall survival (OS) rates were 86.6% and 67.4% at 5 and 10 years after LR, respectively. During a median follow-up of 59 months, 211 patients experienced recurrences including 175 (37.4%) within MC and 36 (7.7%) beyond MC. Survival was lowest in patients with beyond MC-recurrence followed by within MC- and no-recurrence groups (26.5%, 86.6%, and 94.7% at 5 years, respectively, P < 0.001). Independent pathologic predictors of recurrence beyond MC were the presence of satellite nodules, microvascular invasion, and unfavorable gross findings (multinodular confluent and infiltrative) (all, P < 0.05). Patients with all three risk factors experienced recurrence with the highest cumulative incidence of mortality. Among 173 patients with recurrence within MC, the cumulative incidence of HCC progression beyond MC despite resection and locoregional treatment (LRT) was 29% and 60% at 5 and 10 years after recurrence, respectively, and their 10-year OS rate was 25.8%. Conclusion: Curative LR achieved a 5-year survival of > 85% in patients with transplantable HCC, but early SLT after recurrence within MC is advocated because of poor survival and high risk of progression thereafter. Further, prophylactic LT could be considered for those with high risk of recurrence. (C) 2019 Published by Elsevier Masson SAS.-
dc.publisherElsevier Masson SAS-
dc.titleSurvival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy-
dc.contributor.affiliatedAuthorSeo, Chung Gyo-
dc.contributor.affiliatedAuthorYim, Sun Young-
dc.contributor.affiliatedAuthorUm, Soon Ho-
dc.contributor.affiliatedAuthorLee, Yoo Jin-
dc.contributor.affiliatedAuthorKim, Tae Hyung-
dc.contributor.affiliatedAuthorLee, Young Sun-
dc.contributor.affiliatedAuthorHan, Na Yeon-
dc.contributor.affiliatedAuthorChoi, Hyuk Soon-
dc.contributor.affiliatedAuthorKim, Eun Sun-
dc.contributor.affiliatedAuthorKeum, Bora-
dc.contributor.affiliatedAuthorSeo, Yeon Seok-
dc.contributor.affiliatedAuthorYim, Hyung Joon-
dc.contributor.affiliatedAuthorKim, Ji Hoon-
dc.contributor.affiliatedAuthorKim, Dong-Sik-
dc.contributor.affiliatedAuthorJeen, Yoon Tae-
dc.contributor.affiliatedAuthorChun, Hoon Jai-
dc.contributor.affiliatedAuthorLee, Hong Sik-
dc.contributor.affiliatedAuthorKim, Chang Duck-
dc.identifier.bibliographicCitationClinics and Research in Hepatology and Gastroenterology, v.44, no.4, pp.532 - 542-
dc.relation.isPartOfClinics and Research in Hepatology and Gastroenterology-
dc.citation.titleClinics and Research in Hepatology and Gastroenterology-
dc.relation.journalResearchAreaGastroenterology & Hepatology-
dc.relation.journalWebOfScienceCategoryGastroenterology & Hepatology-
dc.subject.keywordPlusLONG-TERM SURVIVAL-
dc.subject.keywordPlusCURATIVE RESECTION-
dc.subject.keywordPlusHEPATIC RESECTION-
dc.subject.keywordPlusANTIVIRAL THERAPY-
dc.subject.keywordAuthorHepatocellular carcinoma-
dc.subject.keywordAuthorSalvage Liver transplantation-
dc.subject.keywordAuthorLiver resection-
dc.subject.keywordAuthorMilan criteria-
dc.subject.keywordAuthorRisk factor-
Files in This Item
There are no files associated with this item.
Appears in
5. Others > Others(Medicine) > 1. Journal Articles
2. Clinical Science > Department of Hepato-Biliary-Pancreatic Surgery > 1. Journal Articles
2. Clinical Science > Department of Radiology > 1. Journal Articles
2. Clinical Science > Department of Pathology > 1. Journal Articles
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles


Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Dong-Sik photo

Kim, Dong-Sik
Anam Hospital (Department of Hepato-Biliary-Pancreatic Surgery, Anam Hospital)
Read more


Total Views & Downloads